KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Current Leases (2019 - 2025)

Historic Current Leases for CRISPR Therapeutics AG (CRSP) over the last 7 years, with Q4 2025 value amounting to $18.6 million.

  • CRISPR Therapeutics AG's Current Leases rose 746.18% to $18.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.6 million, marking a year-over-year increase of 746.18%. This contributed to the annual value of $18.6 million for FY2025, which is 746.18% up from last year.
  • Latest data reveals that CRISPR Therapeutics AG reported Current Leases of $18.6 million as of Q4 2025, which was up 746.18% from $18.3 million recorded in Q3 2025.
  • CRISPR Therapeutics AG's 5-year Current Leases high stood at $18.6 million for Q4 2025, and its period low was $8.3 million during Q2 2022.
  • Its 5-year average for Current Leases is $15.0 million, with a median of $15.8 million in 2022.
  • Per our database at Business Quant, CRISPR Therapeutics AG's Current Leases tumbled by 4792.44% in 2022 and then skyrocketed by 7942.42% in 2023.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Current Leases stood at $12.2 million in 2021, then skyrocketed by 30.3% to $15.8 million in 2022, then fell by 1.37% to $15.6 million in 2023, then rose by 10.64% to $17.3 million in 2024, then rose by 7.46% to $18.6 million in 2025.
  • Its Current Leases stands at $18.6 million for Q4 2025, versus $18.3 million for Q3 2025 and $18.0 million for Q2 2025.